w4j3ru | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/87w4j3ru_hasAnnotation_C1422064> <https://research.tib.eu/covid-19/entity/87w4j3ru_hasAnnotation_C1825598> <https://research.tib.eu/covid-19/entity/87w4j3ru_hasAnnotation_C4033631>
?:creator	<https://research.tib.eu/covid-19/entity/Rubattu%2C_Speranza%3B_Gallo%2C_Giovanna%3B_Volpe%2C_Massimo>
?:doi	<https://research.tib.eu/covid-19/entity/10.3389/fcvm.2020.616564>
?:doi	10.3389/fcvm.2020.616564
?:journal	Front_Cardiovasc_Med
?:license	cc-by
?:pdf_json_files	document_parses/pdf_json/4c51a1d7dc8f3b1a598d315af46eb3eebf1c1ddf.json
?:pmc_json_files	document_parses/pmc_json/PMC7728735.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7728735>
?:pmid	<https://research.tib.eu/covid-19/entity/33330677.0>
?:pmid	33330677.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/4c51a1d7dc8f3b1a598d315af46eb3eebf1c1ddf>
?:source	Medline; PMC
?:title	Sacubitril/Valsartan: Potential Impact of ARNi “Beyond the Wall” of ACE2 on Treatment and Prognosis of Heart Failure Patients With Coronavirus Disease-19
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-27

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/87w4j3ru>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/87w4j3ru>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all